Page last updated: 2024-11-01

norfloxacin and Acantholysis Bullosa

norfloxacin has been researched along with Acantholysis Bullosa in 1 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ramsay, B1
Woodrow, D1
Cream, JJ1

Other Studies

1 other study available for norfloxacin and Acantholysis Bullosa

ArticleYear
An acantholytic bullous eruption after norfloxacin.
    The British journal of dermatology, 1993, Volume: 129, Issue:4

    Topics: Drug Eruptions; Epidermolysis Bullosa; Female; Humans; Middle Aged; Norfloxacin; Skin

1993